武汉东方圣龙医药

Wuhan Dongfang Shenglong Pharmaceutical Technology Development Co., Ltd. is a specialized life sciences company based in Wuhan, China, focusing on the research, development, and production of pharmaceutical intermediates and fine chemicals. Established in 2002, the company operates within the Wuhan East Lake High-tech Development Zone (Optics Valley) and provides high-quality chemical building blocks to the global pharmaceutical industry. Their core expertise lies in complex organic synthesis and custom manufacturing of intermediates for various therapeutic areas, including oncology, cardiovascular diseases, and anti-viral treatments. The company serves as a critical supplier in the drug discovery and development pipeline, offering services ranging from laboratory-scale synthesis to industrial production. By maintaining rigorous quality control standards, they support international pharmaceutical partners in the synthesis of active pharmaceutical ingredients (APIs).